Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-09

Clinical Trial Update: Compassionate Use of Omegaven IV Fat Emulsion [Phase 2]

View source ↗

Summary

Phase 2 compassionate-use trial of Omegaven IV fat emulsion for cholestasis, including total parenteral nutrition-induced cholestasis, was terminated; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omegaven IV Fat Emulsion (omega-3 fatty acid lipid emulsion)

Snippet

Sponsor: Cindy Haller | Conditions: Cholestasis, Total Parenteral Nutrition-induced Cholestasis | Phase 2 | Status: TERMINATED | Results posted: 2016-02-09